Salmeterol

Articles · Lactation Safety Information · New Medicines ·

108605008

Articles

Lactation Safety Information

Inhalation

Inhalation
-
Selective beta2 agonist bronchodilator
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
21st April 2017

New Medicines

Central abdominal bulging due to subcutaneous fat in non-obese patients

Information

New formulation
Not Known
Neothetics

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Nov 19 · Nil in Evofem latest quarterly report or pipeline re development of LIPO-202; assume development discontinued [9].

Category

First-in-class arachidonic acid inhibitor and β2 adrenergic receptor agonist for local injection
From 2012 figures, 24% of men and 25% of women are obese. This had increased from 13% and 16% respectively since 1993 [1].
Central abdominal bulging due to subcutaneous fat in non-obese patients
Subcutaneous injection